Skip to main content
HYPD
NASDAQ Crypto Assets

Hyperion DeFi Retires $8.6M Legacy Debt and Launches Share Buyback

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$3.612
Mkt Cap
$56.874M
52W Low
$2.34
52W High
$11.89
52W Position info
54% above low
Off High info
70% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

HYPD sits 54% above its 52-week low of $2.34.

Summary

Hyperion DeFi repaid its $8.6 million legacy loan in full, eliminating all long-term debt, and repurchased 240,124 shares at $3.21 as part of a new capital-optimization effort.


Key Events · Financing and Capital Events · HYPD

  • Legacy Debt Fully Retired

    Repaid $8.6 million to Avenue Capital on September 28, 2026, terminating the loan agreement and releasing all liens on company assets. No early termination penalties were incurred.

  • Share Buyback Commenced

    Repurchased 240,124 HYPD common shares at a weighted average price of $3.21 per share, the first buyback under the new capital-optimization program.

  • Treasury Position

    Held approximately $14.5 million in cash, cash equivalents, and USDC stablecoin as of September 30, 2026, after funding the debt payoff.

  • HYPE Token Sales

    Sold 200,000 HYPE and HYPE liquid staking tokens during Q3 2026; retains 1.85 million Gross HYPE tokens as of September 30, 2026.


Analysis · HYPD · Crypto Assets

Hyperion DeFi has eliminated its last long-term debt and begun returning capital to shareholders. The $8.6 million payoff removes all liens on company assets and ends the Avenue Capital relationship, while the 240,124-share buyback at $3.21 per share is the first repurchase program the company has executed. With $14.5 million in cash and stablecoins remaining after the payoff, the balance sheet is now debt-free, giving management more flexibility to scale its onchain DeFi operations. The buyback is modest relative to the 15.4 million shares outstanding, but the debt retirement is a meaningful capital-structure improvement for a company that only recently completed its transformation away from the legacy Eyenovia biotech business.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HYPD was trading at $3.61 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $56.9M. The 52-week trading range was $2.34 to $11.89. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HYPD - Latest Insights

HYPD
Nov 12, 2026, 9:16 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.84
Real-time Price: $2.38 info
Change: -$0.465 (-16%) info
Market Cap: $36.784M info
HYPD
Nov 12, 2026, 7:13 AM EST
Source: Binance News
Importance Score:
7
Price at Filing: $2.75
Real-time Price: $2.38 info
Change: -$0.375 (-14%) info
Market Cap: $36.784M info
HYPD
Nov 12, 2026, 7:09 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $2.70
Real-time Price: $2.38 info
Change: -$0.325 (-12%) info
Market Cap: $36.784M info
HYPD
Nov 12, 2026, 7:00 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.82
Real-time Price: $2.38 info
Change: -$0.445 (-16%) info
Market Cap: $36.784M info
HYPD
Sep 08, 2026, 8:12 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $3.41
Real-time Price: $2.38 info
Change: -$1.03 (-30%) info
Market Cap: $36.784M info